Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iodoglycerin is a topical antiseptic and demulcent solution typically composed of iodine, potassium iodide, and glycerin. It is widely utilized in clinical practice for the treatment of inflammatory conditions of the oral and pharyngeal mucosa, including gingivitis, tonsillitis, and oral ulcers. The iodine component exerts broad-spectrum antimicrobial activity by oxidizing essential proteins, nucleotides, and fatty acids within bacteria, viruses, and fungi. The glycerin base acts as a viscous vehicle that enhances the contact time of iodine with the mucosal surface while providing a protective, soothing barrier that minimizes irritation and promotes healing. In the context of tongue mucosal urethral substitution surgery, iodoglycerin is applied to the donor site on the tongue to reduce postoperative pain, edema, and the risk of infection, facilitating faster mucosal recovery compared to standard saline-based care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iodoglycerin.